UNSPSC 51143215: Nicotine dihydrochloride

This classification denotes a nicotinic agonist and alkaloid with the molecular formula C10H14N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I16I55623S, chemically known as nicotine dihydrochloride, (-)-, but more generally known as nicotine dihydrochloride, which bears US NIH Compound Identifier 80115. European Medicines Agency schedules nicotine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14645MIG.

Most nations, for tariff purposes, schedule nicotine dihydrochloride under HS 29399990. SMILES: CN1CCC[C@H]1C2CCCNC2.CL.CL.

UNSPSC 51143215 Nicotine dihydrochloride is a Commodity code that shows minimal relevant recent state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, which fall outside the scope of nicotine dihydrochloride as a chemical or pharmaceutical input. The mismatch between the code's nominal scope and the actual procurement suggests either miscoding or that state and local buyers are not actively pursuing nicotine dihydrochloride through standard procurement channels at present.

Seminole County's naloxone solicitation (IFB, response deadline July 26, 2023) calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement is potentially FEMA-funded and includes standard compliance requirements such as drug-free workplace certification, E-Verify, and insurance coverage. Without additional recent opportunities or evidence of active demand for nicotine dihydrochloride itself across state and local jurisdictions, the code does not present a clear pipeline for business development.